Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston

Jan-Åke Gustafsson, University of Houston

Caption: A team led by Dr. Jan-Åke Gustafsson at the University of Houston has demonstrated that the nuclear receptor liver X receptor beta shows promise as a potential therapeutic target for Parkinson's disease, as well as other neurological disorders.

Credit: Thomas Campbell

Usage Restrictions: None

Related news release: Therapeutic avenues for Parkinson's investigated at UH